Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy
Crossref DOI link: https://doi.org/10.1186/s12885-017-3937-6
Published Online: 2018-01-08
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
Saeki, Hiroshi
Emi, Yasunori
Oki, Eiji
Tokunaga, Shoji
Kakeji, Yoshihiro
Akagi, Yoshito
Baba, Hideo
Baba, Eishi
Maehara, Yoshihiko
Funding for this research was provided by:
Yakult Honsha Co., Ltd
Taiho Pharmaceutical Co., Ltd.
